Clinical trials in Poland
11,459 studies list at least one site in Poland. 1,780 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 6,733
- Recruiting
- 1,516
- Terminated
- 1,136
- Active, not recruiting
- 1,086
- Status unknown
- 633
- Not yet recruiting
- 143
Phase
- Phase 3
- 4,943
- Phase 2
- 2,935
- Phase 4
- 569
- Phase 1
- 569
- Early Phase 1
- 14
Most studied here
Who runs them
Hoffmann-La Roche (430) · AstraZeneca (426) · Pfizer (359) · Novartis Pharmaceuticals (338) · Medical University of Warsaw (293) · GlaxoSmithKline (282) · Eli Lilly and Company (260) · Janssen Research & Development, LLC (253)
Studies
Recruiting first, then most recently updated. Showing 50 of 11,459 — search for more.
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionRecruitingNCT06736574Phase 3
- Physiotherapy Management in Women With Urinary IncontinenceRecruitingNCT06581601Not applicable
- A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)RecruitingNCT06338995Phase 3
- A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsRecruitingNCT06094010Phase 3
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineRecruitingNCT04743141Phase 3
- A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)RecruitingNCT06455449Phase 3
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenTRecruitingNCT06059638Not applicable
- Functional Links Between the Temporomandibular Joint and the Pelvis in GynecologyRecruitingNCT05978414Not applicable
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisRecruitingNCT06655155Phase 2
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruitingNCT05076175Phase 2/3
- A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)RecruitingNCT06136559Phase 3
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)RecruitingNCT06667700Phase 3
- Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderRecruitingNCT06830044Phase 3
- Use of tDCS Stimulation in Neurological and Gynaecological ConditionsRecruitingNCT06891690Not applicable
- A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDPRecruitingNCT06920004Phase 3
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruitingNCT06937086Phase 3
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruitingNCT06937099Phase 3
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)RecruitingNCT06672549Phase 3
- Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailureRecruitingNCT06651970Phase 4
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerRecruitingNCT06890598Phase 3
- A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Phase 3
- Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruitingNCT04649242Phase 3
- Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)RecruitingNCT04728893Phase 2
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruitingNCT05457283Phase 3
- TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological SymptomsRecruitingNCT07490418Not applicable
- A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)RecruitingNCT07624305Phase 3
- Pridopidine Phase 3 Study in Huntington's DiseaseRecruitingNCT07609108Phase 3
- A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07194850Phase 2/3
- A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruitingNCT07475806Phase 2
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.RecruitingNCT07596849Phase 3
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRecruitingNCT07069712Phase 2
- A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous DurvalumabRecruitingNCT07391670Phase 1
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)RecruitingNCT07157774Phase 3
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruitingNCT07091630Phase 3
- A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation ProcedureRecruitingNCT07353710Not applicable
- ENDoscopic Assessment in Acute PANcreatitis Study (ENDOPAN Study)RecruitingNCT07714850
- ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to EfgartigimodRecruitingNCT07284420Phase 2
- Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With AchondroplasiaRecruitingNCT07441876Phase 2/3
- ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia GravisRecruitingNCT07294170
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.RecruitingNCT07028853Phase 3
- Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT07284459Phase 2
- Risk Factors and Exercise Effects on Abdominal Separation in SeniorsRecruitingNCT07839572Not applicable
- Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilateral DBS-STN Stimulation - a Randomized Controlled Trial.RecruitingNCT07838636Not applicable
- Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)Enrolling by invitationNCT06605105Phase 3
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)RecruitingNCT06312176Phase 3
- Safety and Effectiveness of Optomesh 3D for Inguinal Hernia RepairNot yet recruitingNCT07836179
- A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%RecruitingNCT06561386Phase 3
- A Study of Pirtobrutinib in Participants With Immune ThrombocytopeniaRecruitingNCT06721013Phase 1/2
- Pan Tumor Rollover StudyRecruitingNCT03899155Phase 2